<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Custom Neoepitopes — OncoSyNex</title>
  <link rel="stylesheet" href="../../assets/styles.css?v=30" />
</head>
<body>
  <header class="site">
    <div class="container nav">
      <a class="brand" href="../../"><span class="logo"></span><span class="brand-text">OncoSyNex</span></a>
      <nav class="menu">
        <a href="../../">Home</a>
        <a href="../immunoai/">ImmunoAI</a>
        <a href="../bioinformatics/">Bioinformatics</a>
        <a href="./">Antigens</a>
      </nav>
    </div>
  </header>

  <section class="hero">
    <div class="container">
      <h1>Custom Neoepitopes</h1>
      <p class="lead">Patient-specific peptides from ranked candidates, formatted for Class I/II immunogenicity assays (RUO).</p>
    </div>
  </section>

  <section>
    <div class="container grid cols-3">
      <div class="card">
        <h3>Inputs</h3>
        <p class="muted">
          • Ranked candidate list (CSV/TSV)<br>
          • Peptide sequence(s) or genomic coords<br>
          • Optional: HLA types, desired lengths, purity tier
        </p>
      </div>
      <div class="card">
        <h3>Design Options</h3>
        <p class="muted">
          • Length: 8–11mers (Class I), 13–25mers (Class II)<br>
          • Pooling strategy (per-antigen / per-patient)<br>
          • Modifications (N-terminal acetylation, etc.)<br>
          • Purity: 70% / 80% / 90% / >95%
        </p>
      </div>
      <div class="card">
        <h3>QC & Deliverables</h3>
        <p class="muted">
          • LC-MS/HPLC purity report (per peptide)<br>
          • Lyophilized individual vials or pooled sets<br>
          • Composition sheet & handling notes
        </p>
      </div>
    </div>
  </section>

  <section>
    <div class="container grid cols-3">
      <div class="card">
        <h3>Lead Time</h3>
        <p class="muted">Standard: 2–3 weeks. Large sets or high-purity may extend timelines.</p>
      </div>
      <div class="card">
        <h3>Typical Use</h3>
        <p class="muted">ELISpot/ICS, tetramer generation, T-cell priming, validation screens.</p>
      </div>
      <div class="card">
        <h3>Request a Quote</h3>
        <p class="muted">Send your list to <b>hello@oncosynex.com</b> with HLA and purity preferences.</p>
      </div>
    </div>
  </section>

  <footer class="site">
    <div class="container">
      <p class="copyright">© <span id="y"></span> OncoSyNex • Research Use Only (RUO)</p>
    </div>
  </footer>
  <script>document.getElementById('y').textContent=new Date().getFullYear()</script>
</body>
</html>
